Corrigendum to: "The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart® and Tamsulosin (CombAT) Study" [Eur Urol Suppl 2008;7:171 (Abstract no. 403)]

Corrigendum to: "The Influence of Baseline Parameters on Changes in IPSS with Dutasteride, Tamsulosin, and Combination Therapy: Two-Year Data from the Combination of Avodart^® and Tamsulosin (CombAT) Study" [Eur Urol Suppl 2008;7:171 (Abstract no. 403)]

Eur Urol. 2009 Apr;55(4):1000-1001. doi: 10.1016/j.eururo.2008.06.035. Epub 2008 Jun 20.

¹ Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USA. Electronic address: claus.roehrborn@utsouthwestern.edu.
² 2nd School of Medicine, La Sapienza University, Rome, Italy.
³ Department of Urology, Universita Vita Salute San Raffaele, Milan, Italy.
⁴ Department of Urology, Galliera Hospital, Genova, Italy.
⁵ CMC Foch, Service d'Urologie, Suresnes, France.
⁶ Hospital Juan Canalejo 1, La Coruña, Spain.
⁷ CMX Research Inc. & University of Toronto, Toronto, Ontario, Canada.
⁸ GlaxoSmithKline Clinical Development and Medical Affairs, Madrid, Spain.
⁹ Department of Biostatistics, GlaxoSmithKline, Research Triangle Park, NC, USA.

No abstract available